Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Neoplasms | 4 | 2022 | 496 | 1.070 |
Why?
|
| Melanoma | 3 | 2023 | 272 | 0.850 |
Why?
|
| Carcinoma, Basal Cell | 2 | 2022 | 40 | 0.840 |
Why?
|
| Pigmentation | 1 | 2023 | 8 | 0.790 |
Why?
|
| Body Piercing | 1 | 2022 | 1 | 0.740 |
Why?
|
| Cosmetic Techniques | 1 | 2022 | 6 | 0.740 |
Why?
|
| Viral Nonstructural Proteins | 3 | 2008 | 61 | 0.620 |
Why?
|
| Hepacivirus | 3 | 2008 | 103 | 0.610 |
Why?
|
| RNA Helicases | 2 | 2008 | 29 | 0.560 |
Why?
|
| Wound Closure Techniques | 1 | 2017 | 4 | 0.550 |
Why?
|
| Mohs Surgery | 1 | 2017 | 13 | 0.550 |
Why?
|
| DNA | 3 | 2008 | 544 | 0.350 |
Why?
|
| Postoperative Complications | 1 | 2017 | 1065 | 0.330 |
Why?
|
| Oligonucleotides | 1 | 2008 | 76 | 0.290 |
Why?
|
| Base Pairing | 1 | 2008 | 27 | 0.280 |
Why?
|
| RNA | 1 | 2008 | 174 | 0.260 |
Why?
|
| Hair | 1 | 2023 | 29 | 0.200 |
Why?
|
| Dermatology | 1 | 2019 | 54 | 0.150 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 112 | 0.150 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 169 | 0.140 |
Why?
|
| Substrate Specificity | 2 | 2008 | 197 | 0.140 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2018 | 44 | 0.140 |
Why?
|
| Cicatrix | 1 | 2017 | 42 | 0.130 |
Why?
|
| Organ Transplantation | 1 | 2017 | 49 | 0.130 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2017 | 41 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 287 | 0.120 |
Why?
|
| Humans | 7 | 2023 | 52441 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 601 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 331 | 0.100 |
Why?
|
| Female | 5 | 2022 | 28277 | 0.100 |
Why?
|
| Sporothrix | 1 | 2012 | 2 | 0.090 |
Why?
|
| Chin | 1 | 2012 | 5 | 0.090 |
Why?
|
| Sporotrichosis | 1 | 2012 | 4 | 0.090 |
Why?
|
| Bicycling | 1 | 2012 | 29 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 260 | 0.090 |
Why?
|
| Catalysis | 2 | 2008 | 88 | 0.090 |
Why?
|
| Middle Aged | 3 | 2022 | 13133 | 0.090 |
Why?
|
| Adenosine Triphosphatases | 2 | 2008 | 91 | 0.080 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 27 | 0.070 |
Why?
|
| RNA, Double-Stranded | 1 | 2008 | 23 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 79 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 300 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2008 | 108 | 0.070 |
Why?
|
| Poly U | 1 | 2008 | 5 | 0.070 |
Why?
|
| Surface Plasmon Resonance | 1 | 2008 | 19 | 0.070 |
Why?
|
| Male | 5 | 2019 | 26874 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2017 | 5508 | 0.070 |
Why?
|
| Protein Binding | 1 | 2008 | 673 | 0.060 |
Why?
|
| Adult | 2 | 2017 | 14205 | 0.060 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2019 | 35 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 498 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 735 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 1120 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1096 | 0.030 |
Why?
|
| Aged | 2 | 2018 | 10242 | 0.030 |
Why?
|
| Accidents | 1 | 2012 | 19 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 2294 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 3449 | 0.020 |
Why?
|
| Chromatography | 1 | 2008 | 11 | 0.020 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2008 | 13 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 3971 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2008 | 27 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2008 | 40 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 2008 | 42 | 0.020 |
Why?
|
| Light | 1 | 2008 | 50 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 4346 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 613 | 0.020 |
Why?
|
| United States | 1 | 2017 | 5215 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2008 | 147 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 6713 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 6694 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 2987 | 0.010 |
Why?
|
| Child | 1 | 2012 | 7194 | 0.010 |
Why?
|